Lakefront Biotherapeutics reported EUR-0.23 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 -0.04 -0.65 -3.07 Nov/11
FY2026Q1 Jun/2026 -0.20 -0.60 -1.58 Aug/10
FY2026Q1 Mar/2026 0.21 -1.21 -2.35 May/06
FY2025Q4 Dec/2025 11.89 -0.17 0.29 Feb/23
FY2025Q3 Sep/2025 -3.07 -0.41 -0.74 Nov/05




Eps Change Date
argenx SE USD 7.8 1.36 Sep/2026
AstraZeneca USD 2.79 0.16 Sep/2026
Biogen USD 2.62 0.98 Sep/2026
Genmab DKK 5.43 4.6 Jun/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
GRIFOLS EUR 0.3 0.07 Sep/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Incyte USD -3.6 6.69 Sep/2026
Merck EUR 2.04 2.58 Sep/2026
Neurocrine Biosciences USD 3.29 0.44 Sep/2026
Novartis USD 2.46 0.05 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 3.55 1.46 Sep/2026
UCB EUR 5.65 3.21 Dec/2025
Vertex Pharmaceuticals USD 4.76 0.03 Sep/2026